With your help, we can help others in the future

In addition to pursuing a cure for the rising epidemic of diabetes, clinical research offers people living with the disease the opportunity to access new therapies and resources for treatment and an improved quality of life.

Carefully conducted clinical research trials, which study human volunteers to answer specific health questions, are the fastest and safest way to find treatments that work in people and ways to improve health.

The Scripps Whittier Diabetes Institute conducts clinical trials on an ongoing basis for people with type 1 and type 2 diabetes. Trials are conducted in La Jolla and Chula Vista clinic sites by a clinical research team of experienced physicians, nurses, and others, many of whom are bilingual in English and Spanish.

All team members provide culturally sensitive education, care and service with a special focus on patients and their families.

See our list of program locations (PDF, 65 KB) to find the clinical research sites.

Participate in a trial

If you or someone you know is interested in participating in a clinical trial, please contact us at 858-626-5678 to find out more.

• Have type 1 diabetes or are a family member of someone with type 1 diabetes
• Have type 2 diabetes and are not taking medication for diabetes
• Have type 2 diabetes and are managing your diabetes with diet and exercise, or oral or injectable medication

Qualified participants may receive investigational medication, study-related physical exam and blood tests, and compensation for time and travel.

Type 1 Diabetes Clinical Trial

Scripps Whittier clinical trials is conducting a study of an investigational treatment for people recently diagnosed with type 1 diabetes.

What is the purpose of this study?

This study is being conducted to test the effectiveness and safety of an experimental agent called Prochymal. Prochymal is an adult human stem cell therapy being tested for use in type 1 diabetes mellitus.

This study will test whether Prochymal can treat patients’ type 1 diabetes mellitus in combination with the standard care they would receive from a doctor according to ADA clinical practice recommendations

For more information, contact:

Rosario Rosal, RN, study coordinator
858-626-5695
Rosal.Rosario@scrippshealth.org